Newsquawk Logo

Merck (MRK) reportedly cutting workforce at the Gardasil plant, citing falling global demand, according to reports

Merck's decision to cut its workforce at the Gardasil plant highlights the challenges posed by declining global demand for its vaccine.

Newsquawk StaffPublished On the live feed at — 2 more headlines followed before this page went public
Newsquawk headlinesUTC

US official denies news of evacuation of US embassy staff in Baghdad, via Al Arabiya

Merck's (MRK) KEYTRUDA plus paclitaxel with or without bevacizumab is the first PD-1 inhibitor-based regimen to show a statistically significant improvement in OS regardless of PD-L1 status

Merck (MRK) reportedly cutting workforce at the Gardasil plant, citing falling global demand, according to reports

China’s coordinated policies, full industrial system, and vast domestic market are expected to deliver steady, high-quality growth and a strong start to the 15th Five-Year Plan, Global Times reports

US Construction Spending MoM (Nov) M/M -0.2% (Prev. 0.5%)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
Context

This move is a potential signal of broader issues within the pharmaceutical sector, possibly impacting investor sentiment towards Merck and its peers. Watch for implications on stock performance and any strategic shifts in the company or industry as they respond to changing market dynamics.

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.